Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001008315-05-000002

Options or other derivatives

  • Chief Scientific Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SKOLNICK MARK H · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2005-02-17 Grant or award : show line 1 in the form Incentive Stock Option (right to buy) +4,520 $22.12 2015-02-17 4,520 4,520 D
2005-02-17 Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) +25,480 $22.12 2015-02-17 25,480 25,480 D
Loading xslF345X02/edgardoc.xml…